Coronavirus
-
Here are revised rules for International arrivals amid concerns of Omicron
India -In the wake of concerns regarding the latest variant Omcorn, the Indian government has decided to revise the rules on international arrivals as ... -
Lancet Study: Covishield vaccine remained efficient during Delta surge
India -The prestigious journal The Lancet Infectious Diseases has published a study, according to which the Covishield vaccine remained effective against moderate to severe ... -
Omicron Virus: India’s Union Health Ministry Updates Covid Guideline for International Passengers
South Africa -India’s Union Health Ministry refreshes Covid-19 rules for international tourists, realized from 1 December 2021. Foreign tourists will require to submit 14 ... -
PM Modi discusses raising concerns about Covid-19 new variant
Delhi -The latest Covid-19 variant has been found in South Africa concerning leaders all around the world. Now that they are aware of the ... -
Covaxin Efficacy Determined At 50Percent: First World Study
New Delhi -According to a study published in The Lancet Infectious Diseases Journal, after assessing 2714 hospital workers at AIIMS, New Delhi, it was ... -
India green lights clinical trials of Akston Biosciences’ second-generation vaccine
India -India kicks off clinical trials for the second generation Covid-19 vaccine of the US-based Akston Biosciences. The US firm has announced that the ... -
CoWIN App: Over 12 Nations in Discussions with Modi Govt to Borrow the Technology
Delhi -The Indian government’s official web portal for the COVID-19 vaccination, the CoWIN app, is soon to be used globally as more than 12 ... -
As ‘Covaxin’ gets a nod from WHO, India expects more nations to give emergency approval
Delhi-On November 3, World Health Organization (WHO) gave emergency use approval for coronavirus to India’s first indigenous jab, Bharat Biotech’s ‘Covaxin’ vaccine. Hyderabad-based Bharat ... -
After much delay, Covaxin gets WHO’s approval
Hyderabad -Bharat Biotech manufactured Covaxin has finally got the approval of the World Health Organization on Wednesday. It is India’s first indigenous Covid vaccine. ... -
Opposition Calls One Billion Vaccine Story As ‘Jumla Version’
Delhi -Calling it an aggregate version or Jumla version, Rahul Gandhi has ridiculed the 100-crore new marketed by the Centre over a landmark achievement ...
